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Effects of Diltiazem on Left Ventricular Diastolic Behavior in Patients
With Hypertrophic Cardiomyopathy: Evaluation With Exercise Pulsed
Doppler Echocardiography
MASATSUGU IWASE , MD, IWAO SOTOBATA, MD, SHIGEHITO TAKAGI , MD,
KAZUHIKO MIYAGUCHI, MD, HU XIAO JING, MD, MITSUHIRO YOKOTA , MD
Nagoya. Japan
To estimate the effects of diltiazem on the left ventricular
diastolic abnormalities in patients with hypertrophic
cardiomyopathy, transmitral flow velocity during dias-
tole was studied before and immediately after dynamic
leg exercise with the pulsed Doppler technique combined
with two-dimensional echocardiography. Seventeen pa-
tients with hypertrophic cardiomyopathy and 24 appar-
ently healthy men performed bicycleergometer exercise
in the supine position with the target heart rate set at
120 beats/min. The patients with cardiomyopathy were
directed to perform the exercise at the same intensity
after receiving 30 to 60 mg of diltiazem, three times
daily, for 1 or 2 weeks. The pattern of transmitral flow
velocityin diastole had two components, one correspond-
ing to the rapid filling phase in early diastole and the
other to the atrial contraction phase in late diastole. To
assess left ventricular diastolic behavior, the following
Hypertrophic cardiomyopathy is a specific myocardial dis-
ease in which reduced compliance and impaired diastolic
filling are associated with abnormal left ventricular hyper-
trophy (1,2) . Recently, several investigators reported the
effectiveness of the slow calcium channel blocking agents,
such as verapamil (3), nifedipine (4) and diltiazem (5), in
treating patients with hypertrophic cardiomyopathy . How-
ever , few data (6,7) are available on the effect s of these
drugs on the response of left ventricular diastolic behavior
to exercise. To estimate the effect s of diltiazem on the Icft
ventricular diastolic abnormalities in patients with hyper-
trophic cardiomyopathy, transmitral flow velocity during
diastole was studied before and immediately after dynamic
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variables were analyzed: peak velocityin the rapid filling
and atrial contraction phases, the ratio of peak velocity
in the atrial contraction phase to that in the rapid filling
phase, and pressure half-time.
The changes in peak velocity in the atrial contraction
phase, pressure half-time and the ratio of peak velocity
in the atrial contraction phase to that in the rapid filling
phase with exercise differed significantly between pa-
tients with hypertrophic cardiomyopathy with no med-
ication and control subjects. After diltiazem, the re-
sponse of these variables to exercise was almost identical
in the two groups. These results suggest that diltiazem
can lessen the left ventricular diastolic abnormality in
patients with hypertrophic cardiomyopathy on dynamic
exercise of mild intensity.
(J Am Coli Cardiol 1987;9:1099-105)
leg exercise using a pulsed Doppler technique combined
with two-dimensional echocardiography.
Methods
Study patients. The study group comprised 17 patients
with hypertrophic cardiomyopathy (15 men and 2 women ,
aged 24 to 69 years [mean 46]) and 24 healthy men (25 to
43 years [mean 34]) as normal control subjects . None of
the healthy men had a significant past history and none
shuwed abnormalities on physical , electrocardiographic and
echocardiographic examinations. The diagnosis of hyper-
trophic cardiomyopathy was based on echocardiographic
study in all patients and on right- and left-sided cardiac
catheterization in 14 patients . The echocardiographic cri-
terion for hypertrophi c cardiom yopathy was the dispropor-
tionate thickening (> 15 mm) of the ventricular septum in
the absence of other acquired or congenital heart disease.
The mean thickness of the interventricular septum in patients
with hypertrophic cardiomyopathy was 22 ± 4 mm (range
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16to 29); the mean posterior wall thickness in these patients
was 10 ± 2 mm (range 8 to 12). All subjects had normal
sinus rhythm.
Pulsed Doppler echocardiography. The pulsed Dop-
pler system (ATL Mark V, ATL 500 or Aloka SSD-
720+ UGR-23) was used with a 3 MHz transducer, com-
bined with a two-dimensional echocardiograph with me-
chanical sector scanning. The two-dimensional echocardio-
gram in the apical long-axis view was monitored with the
subjects in the supine position, breathing normally, and the
sampling site was positioned at the center of the mitral ring.
True transmitral flow velocity from the mitral ring to the
apex was calculated from the shifted frequency using the
Doppler equation. The pattern of transmitral flow velocity
in diastole had two components. The first corresponded to
the rapid filling phase in early diastole, and the second to
the atrial contraction phase in iate diastole. The peak ve-
locity in the rapid filling and atrial contraction phases, the
ratio of peak velocity in the atrial contraction phase to that
in the rapid filling phase, and pressure half-time (8) were
measured to analyze left ventricular diastolic behavior (Fig.
I). These variables were measured at the darkest portion of
the Doppler flow velocity spectrum and averaged for five
consecutive cardiac cycles.
Doppler measurements after exercise. Multistage ex-
ercise testing was carried out using a bicycle ergometer with
subjects in the supine position. The initial load, 25 W for
patients with hypertrophic cardiomyopathy and 50 W for
healthy subjects, was increased by 25 W every 3 minutes.
The exercise end point was a target heart rate of 120 beats/min.
After oral administration of diltiazem, 30 to 60 mg three
times daily for I or 2 weeks, patients with hypertrophic
cardiomyopathy were again directed to perform bicycle er-
gometer exercise of the same intensity as the control ex-
ercise. To analyze the two components of the transmitral
flow velocity patterns, the data at rest and at the first minute
postexercise were statistically analyzed because, at a rapid
heart rate (>90 beats/min), the peak velocity due to atrial
contraction was superimposed on that in the rapid filling
phase in patients with hypertrophic cardiomyopathy. These
two components could not be identified separately.
Statistics. Statistical significance of the results was de-
termined by the analysis of variance (9) for comparison in
normal subjects and patients with hypertrophic cardio-
myopathy before and after diltiazem administration. Dif-
ferences were regarded as significant at a probability (p)
level of <0.05.
Results
The individual and mean values of pulsed Doppler echo-
cardiographic measurements before and after diltiazem ther-
apy are listed in Table I for patients with hypertrophic
cardiomyopathy and those for healthy subjects are listed in
Table 2. The analysis of variance with repeated measures
is listed in Tables 3 and 4. Heart rate increased significantly
from the rest state to the first minute of recovery before and
after diltiazem in both the patient group and the healthy
subjects. It showed no significant differences with diltiazem
administration. The peak velocity in the rapid filling phase
increased significantly with diltiazem in the patient group,
and this increase was more significant with exercise. The
pressure half-time decreased significantly with diltiazem in
the patient group. The peak velocity in the atrial contraction
phase increased insignificantly with diltiazem in this group
and this increment was significantly decreased with exer-
cise. The ratio of peak velocity in the atriai contraction phase
to that in the rapid filling phase decreased significantly with
n
• I V
: 1 P AC
i \
Figure 1. Transmitral flow velocity profile and the
four variables derivedfrom the transmitral flow ve-
locity pattern. The measurements of transmitral flow
velocity used in this study are I) the peak velocity
in the rapid filling phase (PVRF, cm/s); 2) the peak
velocity in the atrial contraction phase (PVAC, cm/s);
3) the ratioof peak velocity in the atrial contraction
phase to that in the rapid filling phase; and 4) the
pressure half-time (PH!, ms). The pressure half-
time is the time required for the maximal velocity
curve of the rapid filling phase to fall from peak
velocity to peak velocity divided by v2 ECG =
electrocardiogram.
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Table 1. Pulsed Doppler Echocardiographic Variables at Rest and at I Minute After Exercise, Before and After Diltiazem Therapy
in Patients With Hypertrophic Cardiomyopathy
HR PVRF PHT PVAC
(min-I) (cm/s) (ms) (cm/s) AIR
Age (yr)
Case & Sex Group Rest Rec I Rest Rec I Rest Rec I Rest Rec I Rest Rec I
27M C 67 73 50 49 64 64 58 68 1.16 1.39
0 57 79 59 77 64 54 41 59 0.69 0.77
2 53M C 74 94 66 66 41 87 59 66 0.89 1.00
0 77 91 79 93 41 41 74 60 0.94 0.65
3 37M C 63 74 44 47 64 99 46 56 1.05 1.19
0 58 65 57 70 64 55 50 62 0.88 0.89
4 62M C 56 71 28 33 90 81 44 66 1.57 2.00
0 65 65 25 40 76 76 39 55 1.56 1.38
5 69M C 59 63 38 43 77 67 34 49 0.89 1.14
0 55 64 47 50 55 47 38 50 0.81 1.00
6 57M C 65 87 49 55 85 77 61 74 1.24 1.35
0 68 83 62 66 92 83 71 74 1.15 1.12
7 41M C 71 100 61 72 83 93 45 72 0.74 1.00
0 57 77 65 80 73 48 37 37 0.57 0.46
8 56M C 59 76 57 68 74 74 51 55 0.89 0.81
0 62 82 54 66 76 83 44 62 0.81 0.94
9 50M C 56 72 59 61 64 62 42 65 0.71 1.07
0 66 90 68 72 54 39 48 54 0.71 0.75
10 63M C 74 88 37 49 III 159 55 84 1.49 1.71
0 79 90 42 52 90 93 66 81 1.57 1.56
II 44M C 68 86 50 54 62 58 34 50 0.68 0.93
0 66 95 53 56 52 60 35 60 0.66 1.07
12 47M C 66 80 58 61 62 64 37 47 0.64 0.77
0 56 69 55 62 51 52 29 36 0.53 0.58
13 34M C 67 84 70 70 58 52 46 50 0.66 0.71
0 66 82 72 80 41 35 48 54 0.67 0.68
14 29M C 66 83 65 72 41 41 48 54 0.74 0.75
0 65 80 74 87 35 33 52 52 0.70 0.60
15 49M C 90 103 40 66 III 87 71 88 1.78 1.33
0 75 90 68 83 55 47 59 64 0.87 0.77
16 46F C 60 83 46 54 52 47 36 61 0.78 1.13
0 83 100 65 86 47 41 70 74 1.08 0.86
17 24F C 71 100 69 71 49 44 42 61 0.61 0.86
0 60 85 71 100 47 35 29 45 0.41 0.45
Mean ± SO C 67 ± 8 83 ± II 52 ± 12 58 ± 12 70 ± 21 74 ± 28 48 ± 10 63 ± 12 0.97 ± 0.36 1.13 ± 0.35
0 66 ± 9 82 ± II 60 ± 13 72 ± 16 59 ± 17 54 ± 19 49 ± 15 58 ± 12 0.86 ± 0.32 0.85 ± 0.30
AIR = ratio of peak velocity in the atrial contraction phase to that in the rapid filling phase; C = control; 0 = diltiazem; HR = heart rate;
PHT = pressure half-time; PVAC = peak velocity in the atrial contraction phase; PVRF = peak velocity in the rapid filling phase; rec I = recovery
I minute.
diltiazem in the patient group, and this decrease was more contraction phase to that in the rapid filling phase with
significant with exercise (Fig. 2 and Table 3). exercise differed significantly between patients with hyper-
The changes in peak velocity in the rapid filling phase, trophic cardiomyopathy before diltiazem administration and
pressure half-time and ratio of pe...k velocity in the atrial normal subjects (Fig. 2 and Table 4A). After diltiazem, no
Table 2. Pulsed Doppler Echocardiographic Mean Variables at Rest and at 1 Minute After Exercise in 24 Healthy Subjects
HR PVRF PHT PVAC
(min I) (cm/s) (ms) (cm/s) AIR
Rest Rec I Rest Rec I Rest Rec I Rest Rec I Rest Rec I
Mean ± SO 65 ± 7 82 ± 8 82 ± 8 94 ± 10 49 ± 6 43 ± 6 45 ± 6 56 ± II 0.55 ± 0.08 0.60 ± 0.10
for healthy subjects
Abbreviations as in Table I.
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Table 3. Analysis of Variance Before and After Diltiazem in
17 Patients With Hypertrophic Cardiomyopathy
Drug x
Drug Exercise Exercise
HR 0.35 137.54:\: 0.17
PVRF 26. 55:\: 57.76:\: 7.04*
PHT 17.43:\: 0.04 3.65
PVAC 0.53 57.55:\: 5.22*
AIR 14.11t 5.30* 6.60*
PVRF
em/sec
PVAC
em/sec
*p < 0.05; tp < 0.01; :\:p < 0.001. Values indicate F value. Abbre-
viations as in Table I. P.H.T
msec
100
rest I I' rest
AIR
1.5
significant changes in each variable with exercise were ob-
served between patients with hypertrophic cardiomyopathy
and normal subjects (Fig. 2 and Table 4B). 1.0
Figure 2. Changes inDopplervariables withexercisein 24 normal
subjects (D) and 13 patients with hypertrophic cardiomyopathy
(HCM) with (0) and without (e) diltiazem. AIR = ratio of peak
velocity in the atrial contraction phase (PVAC) to that in the rapid
filling phase (PVRF); rec = recovery; P.H.T. = pressure half-
time.
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Discussion
Evaluation of left ventricular diastolic behavior by
pulsed Doppler echocardiography. Strictly speaking, de-
creased left ventricular compliance, that is, decreased left
ventricular volume change for a given increment in left
ventricular diastolic pressure (10), cannot be proved from
our study. In clinical practice, it is very difficult both to
calculate cineangiographically true left ventricular chamber
volume in patients with hypertrophic cardiomyopathy and
to obtain high fidelity pressure tracings during dynamic ex-
ercise. The recent demonstration that pulsed Doppler echo-
cardiograms of left ventricular inflow velocity could reflect
*p < 0.05; tp < 0.01; :\:p < 0.001. Values indicate F value. Abbre-
viations as in Table 1.
Table 4. Analysis of Variance in 24 Normal Control Subjects
and 17 Patients With Hypertrophic Cardiomyopathy Before and
After Diltiazem
the left ventricular volume changes in diastole has opened
the possibility of a noninvasive approach to the study of left
ventricular diastolic behavior in patients with various heart
diseases, irrespective of the presence of left ventricular de-
formity (11-13). Using quantitative analysis of cineangio-
graphic left ventricular volume curves, Hammermeister and
Warbasse (14) reported that most patients with chronic heart
disease, regardless of lesions, had an abnormally decreased
early diastolic filling rate of left ventricular volume and a
larger increment in diastolic left ventricular volume due to
atrial contraction.
Left ventricular diastolic behavior in hypertrophic
cardiomyopathy: effect of diltiazem. The healthy subjects
in our study demonstrated a markedly increased rapid filling
velocity of the left ventricle after mild dynamic exercise
(Fig. 3), whereas patients with hypertrophic cardio-
myopathy showed only a minimal increase in this variable
(Fig. 4). The increase in flow velocity during the left atrial
contraction phase during and after exercise was nearly par-
allel to the increase in rapid filling velocity of the left ven-
tricle in healthy subjects, and was much more marked in
patients with hypertrophic cardiomyopathy. This augmented
atrial contribution to dynamic exercise seems to be due to
a compensatory mechanism for poor left ventricular disten-
0.00
8.36t
4.99*
1.09
4.70*
0.14
0.09
0.03
0.79
1.58
Effects Within Subjects
Groups x
ExerciseExercise
Effects
Between
Subjects, Groups
A. Before Diltiazem
HR 0.46 215.89:\:
PVRF 11O.15:\: 78.90:\:
PHT 29.78:\: 0.56
PVAC 2.87 68.20:\:
AIR 44.53:\: 14.72t
B. After Diltiazem
HR 0.01 199.56:\:
PVRF 37.89:\: 116.08:\:
PHT 8.30t 22.16:\:
PVAC 0.78 40.42:\:
AIR 19.39:\: 1.60
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Figure 3. Exercise pulsed Dopplerechocardio-
grams in a 25 year old healthy man. Heart rate,
peak velocity in the rapid filling phase and peak
velocity in the atrial contraction phase increase
during exercise, but pressure half-time shortens
and the ratio of peak velocity in the atrial con-
traction phase to that in the rapid filling phase
does not change. The rapid filling and left atrial
contraction flow tracings are not superimposed
throughout the exercise test. Duringthe recovery
phase, these variables return gradually to rest
levels except for the ratio of peak velocity in the
atrial contraction phase to that in the rapid filling
phase. This variable does not change before,
during or after exercise. ECG = electrocardio-
gram.
sibility in patients with hypertrophic cardiomyopathy. After
diltiazemadministration in these patients. the leftventricular
inflow velocity increased more markedly in the rapid filling
phase and, in contrast, less markedly in the atrialcontraction
phase at I minute after exercise (Fig. 5).
Augmentation of the left atrial contribution to left ven-
tricular filling with aging was reported by Miyatake et al.
(1 5). In our study we had some problems comparing left
ventricular diastolic behavior in patients with hypertrophic
cardiomyopathy and in a relatively younger normal control
group. However, this behavior improved after diltiazem in
the patients with cardiomyopathy, approaching that in nor-
mal subjects. This result suggests that diltiazem can lessen
abnormal left ventricular diastolic behavior in patients with
RecoveryExerciseRest
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Figure 4. Case 6. Exercise pulsed Doppler
echocardiograms in a 51 year old man with hy-
pertrophic cardiomyopathy before diltiazem
administration. At rest, the transmitral fl ow ve-
locity pattern shows depressed peak velocity in
the rapid filling phase, prolonged pressure half-
time and increased peak velocity in the atrial
contraction phase and increased ratio of peak
velocity in the atrial contraction phase to that in
the rapid filling phase compared with fi ndings
in normal subjects. During exercise, peak ve-
locity in the rapid filling phase increases very
little, pressure half-time prolongs and peak ve-
locity in the atrial contraction phase and the ratio
of peak velocity in the atrial contraction phase
to that in the rapid filling phase increase mark-
edly. During the fifth minute of exercise, at a
heart rate of 86 beats/min, the rapid fi lling and
atrial contraction flowtracings overlap and could
not be identified separately. After exercise, these
two components separate again. Peak velocity
in the rapid filling phase increases very little and
pressure half-time prolongs, whereas peak ve-
locity in the atrial contraction phase and the ratio
of peak velocity in the atrial contraction phase
to that in the rapid filling phase increase mark-
edly. These variables require more than 5 min-
utes to return to preexercise levels. These mark-
edly increased Doppler echocardiographic
variables represent the left atrial compensatory
mechanism for the poor left ventricular disten-
sibility during and after dynamic exercise. ECG
= electrocardiogram.
1104 IWASE ET AL.
EFFECTS OF DILTIAZEM ON DIASTOLIC BEHAVIOR
lACC VoL 9. No. 5
May 1987:1099- 105
Figure 5. Case 6. Exercise pulsed Doppler
echocardiograms in the same case after dilti-
azem administration. After diltiazem admin-
istration ( 180 mg/day) for I week. the trans-
mitral flow velocity pattern at rest shows
increasedpeak velocity in the rapidfilling phase.
shortened pressure half-time, increased peak
velocity in the atrial contraction phase and un-
changed ratio of peak velocity in the atrial
contraction phase to that in the rapid filling
phase. During exercise, peak velocity in the
rapid filling phase increases, and pressure half-
time does not prolong as compared with the
levels before diltiazem administration. During
the fifth minute of exercise, at a heart rate of
82 beats/min, rapid filling and atrial contrac-
tion flow tracings do not fuse together. After
I minute of exercise, peak velocity in the rapid
filling phase and that in the atrial contraction
phase increase. pressure half-time shortens and
the ratio of peak velocity in the atrial contrac-
tion phase to that in the rapid filling phase does
not change. The increased peak velocity in the
rapid filling phase and reduced pressure half-
time represent improved left ventricular dis-
tensibility as a result of diltiazem therapy, dur-
ing and after dynamic exercise. The smaller
increase in peak velocity in the atrial contrac-
tion phase and unchanged ratio of peak veloc-
ity in the atrial contraction phase to that in the
rapid filling phase demonstrate that improve-
ment of left ventricular distensibility by dilti-
azem does not necessitate the compensatory
mechanism of left atrial contraction.
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hypertrophic cardiomyopathy not only at rest but also after
mild dynamic exercise. There is some possibility that this
might also occur if the left ventricle became less compliant
and left ventricular filling pressure increased markedly (16,17).
When end-diastolic pressure is elevated , the flat portion of
the ven tricul ar function curve is approached and furth er
incremen ts in pressure would have less effect in augmenting
filling volume (Fig . 6). However, it is very unlikely in our
study group, because Nagao et at. (6) reported a diltiazem-
indu ced decrease in exercise-e levated pulmonary arte ry di-
asto lic pressure in patients with hypertrophic cardio-
myop ath y . Hanrath et at. (7) also reported that chronic ve-
rapamil therapy in patients with hypertroph ic cardiomyopathy
showed benefi cial effects on left ventricular hemodynamics
both at rest and during exerc ise , as assessed invas ively by
measurement of pulmonary artery pressure and cardiac out -
put. Th ey also po inted out that with relat ively high doses
of veraparnil, a reduction in heart rate caused improve ment
in diastol ic filling , whi ch , in tum , increased the stroke vol-
ume according to the Frank-Starl ing mech anism.
Mechanism of effects of calcium blocking agents. In
patients with left ventricular hypertrophy secondary to hy-
pertension or aortic stenosis, abnormalities of relaxation and
diastolic filling have been observed (18 ,19) . These ob ser-
vations suggest that subendocard ial ischemia associated with
severe left ventricular hypertrophy may be the cause of
abnormal diastolic function in hypertrophic cardiomyopathy
and other acquired disorders . Furthermore , because calcium
blocking agents block the transport of calcium into both
myocardi al cells and smoo th muscle cells of the coronary
and sys temic arteri es throu gh the slow channel, these agen ts
are ex pec ted to have ce rtai n favo rable effec ts on left ven-
tricul ar relaxation and compliance .
Several groups of investiga tors (4) reported that these
drugs caused an improvement in left ventricular relaxation ,
as reflected in shortened isovolumic relaxation phase and
increased early diastolic filling rate . Moreover, the hered-
itary hypertrophic cardiomyopathy of the Syrian hamster is
reported to be associated with increas ed myocardial calcium
uptake and content, and the development of both metabolic
and pathologic changes can be prevented by the ad minis-
tration of calcium channel blockers (20). Therefore , the
calc ium channel blocking age nt, diltiazem, decreases the
ca lcium influx in the myocardium and could improve the
abnorm al left ventricular diastolic behavior in patients with
hypert rophic cardiomyopathy .
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Figure 6. Changes in left ventricular (LV) pressure and inflow
velocity tracing in a patient with dilated cardiomyopathy. before
and after nitroglycerin (NTG) administration. In the control phase,
the left ventricular inflow velocity tracing shows little atrial con-
tribution to ventricular filling in the presence of a markedly in-
creased left ventricular end-diastolic pressure. After 10 minutes
of sublingual administration of nitroglycerin. end-diastolic pres-
sure decreases markedly and left ventricular inflow velocity dem-
onstrates the large atrial contribution to ventricular filling. The
atrial contribution to filling tends to diminish when left ventricular
filling pressure increases markedly.
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